• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Concomitant Anti-GBM Glomerulonephritis and Acute Interstitial Nephritis Following Programmed Death Receptor-1 Blockade With Nivolumab.

作者信息

Tani Takashi, Sugino Kenta, Hashimoto Kazumasa, Mii Akiko, Kashiwagi Tetsuya, Shimizu Akira, Sakai Yukinao, Iwabu Masato

机构信息

Department of Endocrinology, Metabolism and Nephrology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.

Department of Internal Medicine, Tokyo Rinkai Hospital, Tokyo, Japan.

出版信息

Kidney Int Rep. 2022 Aug 29;7(10):2317-2318. doi: 10.1016/j.ekir.2022.08.020. eCollection 2022 Oct.

DOI:10.1016/j.ekir.2022.08.020
PMID:36217512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9546764/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4b/9546764/dd3f45db4761/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4b/9546764/dd3f45db4761/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4b/9546764/dd3f45db4761/gr1.jpg

相似文献

1
Concomitant Anti-GBM Glomerulonephritis and Acute Interstitial Nephritis Following Programmed Death Receptor-1 Blockade With Nivolumab.使用纳武单抗阻断程序性死亡受体-1后并发抗肾小球基底膜肾小球肾炎和急性间质性肾炎
Kidney Int Rep. 2022 Aug 29;7(10):2317-2318. doi: 10.1016/j.ekir.2022.08.020. eCollection 2022 Oct.
2
Acute interstitial nephritis after sequential ipilumumab - nivolumab therapy of metastatic melanoma.转移性黑色素瘤序贯伊匹单抗-纳武单抗治疗后发生急性间质性肾炎。
J Immunother Cancer. 2017 Jul 18;5(1):57. doi: 10.1186/s40425-017-0261-2.
3
Reintroduction of nivolumab in a patient with gastric cancer after improvement of nivolumab-induced acute interstitial nephritis: a case report.纳武利尤单抗诱导的急性间质性肾炎改善后，一名胃癌患者重新使用纳武利尤单抗：病例报告
Int Cancer Conf J. 2020 May 22;9(3):127-132. doi: 10.1007/s13691-020-00418-2. eCollection 2020 Jul.
4
Association of Acute Interstitial Nephritis with Nivolumab in Renal Cell Carcinoma: A Case Report.肾细胞癌中急性间质性肾炎与纳武单抗的关联：一例报告
Indian J Nephrol. 2021 May-Jun;31(3):303-306. doi: 10.4103/ijn.IJN_62_20. Epub 2021 Feb 20.
5
Blockade of TGF-beta action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis.阻断转化生长因子-β的作用可改善抗肾小球基底膜肾炎的肾功能障碍和组织学进展。
Kidney Int. 2003 Jul;64(1):92-101. doi: 10.1046/j.1523-1755.2003.00045.x.
6
Acute Interstitial Nephritis With Karyomegalic Epithelial Cells After Nivolumab Treatment-Two Case Reports.纳武单抗治疗后伴核大上皮细胞的急性间质性肾炎——两例报告
Clin Med Insights Case Rep. 2019 Jun 13;12:1179547619853647. doi: 10.1177/1179547619853647. eCollection 2019.
7
Nivolumab-associated acute glomerulonephritis: a case report and literature review.纳武单抗相关的急性肾小球肾炎：一例报告及文献综述
BMC Nephrol. 2016 Nov 22;17(1):188. doi: 10.1186/s12882-016-0408-2.
8
Acute tubulointerstitial nephritis and IgM deposits on glomerular capillary walls after immunotherapy with nivolumab for metastatic renal cell carcinoma.纳武利尤单抗免疫治疗转移性肾细胞癌后出现急性肾小管间质性肾炎和 IgM 在肾小球毛细血管壁沉积。
CEN Case Rep. 2020 Feb;9(1):48-54. doi: 10.1007/s13730-019-00424-1. Epub 2019 Oct 11.
9
The Analysis of Renal Infiltrating Cells in Acute Tubulointerstitial Nephritis Induced by Anti-PD-1 Antibodies: A Case Report and Review of the Literature.抗程序性死亡蛋白1（PD-1）抗体诱导的急性肾小管间质性肾炎肾浸润细胞分析：一例报告并文献复习
Intern Med. 2018 Nov 1;57(21):3135-3139. doi: 10.2169/internalmedicine.0444-17. Epub 2018 Jun 6.
10
Nivolumab-induced acute granulomatous tubulointerstitial nephritis in a patient with gastric cancer.纳武利尤单抗致胃癌患者急性粒细胞性间质性肾炎
Invest New Drugs. 2018 Aug;36(4):726-731. doi: 10.1007/s10637-018-0596-7. Epub 2018 Apr 6.

引用本文的文献

1
Durvalumab-Associated Crescentic Glomerulonephritis With IgA Vasculitis-Like Features.伴有IgA血管炎样特征的度伐利尤单抗相关性新月体性肾小球肾炎。
Kidney Int Rep. 2025 May 2;10(7):2489-2490. doi: 10.1016/j.ekir.2025.04.052. eCollection 2025 Jul.
2
Two acute kidney injury episodes after ICI therapy: a case report.免疫检查点抑制剂（ICI）治疗后发生 2 次急性肾损伤：病例报告。
CEN Case Rep. 2024 Oct;13(5):408-415. doi: 10.1007/s13730-024-00855-5. Epub 2024 Mar 7.
3
Pembrolizumab-Induced Anti-GBM Glomerulonephritis: A Case Report.帕博利珠单抗诱导的抗肾小球基底膜肾小球肾炎：一例报告

本文引用的文献

1
Atypical Antiglomerular Basement Membrane Nephritis Following Immune Checkpoint Inhibitor.免疫检查点抑制剂治疗后出现的非典型抗肾小球基底膜肾炎
Kidney Int Rep. 2022 May 3;7(8):1913-1916. doi: 10.1016/j.ekir.2022.04.089. eCollection 2022 Aug.
2
A Systematic Review of Immune Checkpoint Inhibitor-Associated Glomerular Disease.免疫检查点抑制剂相关肾小球疾病的系统评价
Kidney Int Rep. 2020 Oct 16;6(1):66-77. doi: 10.1016/j.ekir.2020.10.002. eCollection 2021 Jan.
3
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.
Kidney Med. 2023 May 30;5(8):100682. doi: 10.1016/j.xkme.2023.100682. eCollection 2023 Aug.
免疫检查点抑制剂相关 AKI 的临床特征和结局：一项多中心研究。
J Am Soc Nephrol. 2020 Feb;31(2):435-446. doi: 10.1681/ASN.2019070676. Epub 2020 Jan 2.
4
Immune checkpoint inhibitor nephrotoxicity: what do we know and what should we do?免疫检查点抑制剂相关肾毒性：我们知道什么？我们应该做什么？
Kidney Int. 2020 Jan;97(1):62-74. doi: 10.1016/j.kint.2019.07.022. Epub 2019 Aug 23.